Insulin resistance impairs nigrostriatal dopamine function.

Morris, J K; Bomhoff, G L; Gorres, B K; Davis, V A; Kim, J; Lee, P-P; Brooks, W M; Gerhardt, G A; Geiger, P C; Stanford, J A

Morris, J K; Bomhoff, G L; Gorres, B K; Davis, V A; Kim, J; Lee, P-P; Brooks, W M; Gerhardt, G A; Geiger, P C; Stanford, J A.

Affiliation

Morris JK; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA.

Exp Neurol ; 231(1): 171-80, 2011 Sep.

Article in En | MEDLINE | ID: mdl-21703262

Subject(s)

Corpus Striatum/physiopathology; Diabetes Complications/metabolism; Dopamine/physiology; Insulin Resistance/physiology; Parkinson Disease/metabolism; Substantia Nigra/metabolism; Animals; Corpus Striatum/metabolism; Diabetes Mellitus, Type 2/complications; Diabetes Mellitus, Type 2/metabolism; Dietary Fats/adverse effects; Dietary Fats/metabolism; Disease Models, Animal; Dopamine/metabolism; Iron/metabolism; Iron Metabolism Disorders/complications; Iron Metabolism Disorders/metabolism; Male; Neural Pathways/metabolism; Parkinson Disease/etiology; Rats; Rats, Inbred F344; Substantia Nigra/pathology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Insulin Resistance / Substantia Nigra / Dopamine / Corpus Striatum / Diabetes Complications Type of study: Etiology_studies / Prognostic_studies Limits: Animals Language: En Journal: Exp Neurol Year: 2011 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google